This company has been acquired
Apollo Endosurgery Management
Management criteria checks 4/4
Key information
Chas McKhann
Chief executive officer
US$2.8m
Total compensation
| CEO salary percentage | 19.8% |
| CEO tenure | 2.1yrs |
| CEO ownership | 0.4% |
| Management average tenure | 4.3yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?
Aug 05Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings
Aug 04Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Mar 02Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?
Aug 04Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy
Jun 28Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?
May 05A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)
Mar 24What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?
Mar 03Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares
Feb 10We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt
Jan 31If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%
Dec 27Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?
Dec 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | US$3m | US$550k | -US$40m |
| Sep 30 2022 | n/a | n/a | -US$41m |
| Jun 30 2022 | n/a | n/a | -US$36m |
| Mar 31 2022 | n/a | n/a | -US$28m |
| Dec 31 2021 | US$9m | US$375k | -US$25m |
Compensation vs Market: Chas's total compensation ($USD2.78M) is about average for companies of similar size in the US market ($USD2.67M).
Compensation vs Earnings: Chas's compensation has been consistent with company performance over the past year.
CEO
Chas McKhann (53 yo)
2.1yrs
Tenure
US$2,780,544
Compensation
Mr. Charles S. McKhann, also known as Chas, serves as President, Chief Executive Officer and Director at Apollo Endosurgery, Inc since March 01, 2021. He served as Chief Commercial Officer at Torax Medical...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.1yrs | US$2.78m | 0.39% $ 2.2m | |
| CFO, Secretary & Treasurer | 1.7yrs | US$1.34m | 0.18% $ 1.0m | |
| Executive Vice President of Operations | 5yrs | US$662.23k | 0.079% $ 460.8k | |
| Co-Founder and Innovation Partner | no data | no data | no data | |
| Co-Founder and Innovation Partner | no data | no data | no data | |
| Co-Founder and Innovation Partner | no data | no data | no data | |
| Co-Founder and Innovation Partner | 18.3yrs | no data | no data | |
| Co-Founder & Chief Medical Officer | no data | US$1.16m | 0.062% $ 361.2k | |
| Co-Founder and Innovation Partner | no data | no data | no data | |
| Co-Founder | 18.3yrs | no data | no data | |
| Investor Relations Manager | no data | no data | no data | |
| Vice President of Legal & Compliance | 3.6yrs | no data | no data |
4.3yrs
Average Tenure
53yo
Average Age
Experienced Management: APEN's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.1yrs | US$2.78m | 0.39% $ 2.2m | |
| Independent Chairman of the Board | 4.1yrs | US$193.24k | 0.051% $ 298.6k | |
| Independent Director | 4.9yrs | US$164.49k | 0.038% $ 218.0k | |
| Independent Director | 11.3yrs | US$165.15k | no data | |
| Independent Director | 8.9yrs | US$169.49k | 0.047% $ 270.3k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 5.4yrs | US$159.70k | 0.0067% $ 38.9k |
5.2yrs
Average Tenure
58.5yo
Average Age
Experienced Board: APEN's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/04/06 21:09 |
| End of Day Share Price | 2023/04/03 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Apollo Endosurgery, Inc. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Hewitt | Craig-Hallum Capital Group LLC |
| Frank Takkinen | Lake Street Capital Markets, LLC |
| Suraj Kalia | Northland Capital Markets |